$10 million for UK's cancer gene project:
This article was originally published in Clinica
A £10 million initiative for identifying genetic abnormalities that cause cancer is to be established in the UK. Funded by Britain's Wellcome Trust, the Cancer Genome project will use rapidly emerging data from the Human Genome Project to find gene abnormalities associated with all forms of human cancers. The new project will be led by Professor Michael Stratton and Dr Richard Wooster at the Sanger Centre in Hinxton, Cambridgeshire.
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.